SCCM is updating its SCCM Connect Community. Access to SCCM Connect may be limited until April 23.

From July 28th through August 2nd, SCCM will be performing maintenance on its websites. Users may experience intermittent issues when trying to access online courses, assessments and director-led portals for online courses.

Tag: Vaccines

Tag Search

visual bubble
visual bubble
visual bubble
visual bubble

A Shot in The Dark: COVID-19 Vaccine Update

A January 8, 2021, SCCM webcast focusing on COVD-19 vaccination served as a primer for healthcare professionals who will be among the first to receive vaccines.


A Shot in The Dark: COVID-19 Vaccine Update

This webcast served as a COVID-19 vaccination primer that can be used by all types of healthcare workers (HCWs) to help them prepare for Operation Warp Speed and the mass vaccination efforts in the United States. This webcast is the first in a series of updates that the SCCM will be producing to better educate clinicians as the vaccination efforts continue internationally. Webcast Recorded on Friday, January 8, 2021


Ethical Considerations for a COVID-19 Vaccine Mandate

Mandate to vaccinate or nudge if there is no budge? COVID-19 vaccines remain a key weapon in the fight against the deadliest modern-day pandemic the world has seen. In this article, we summarize key facts and ethical considerations for healthcare organizations when considering a COVID-19 vaccine mandate for U.S. healthcare workers (HCW).


Can you address some of the issues regarding the AstraZeneca and Johnson & Johnson vaccines being prothrombotic in pregnancy?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on June 9th, 2021


Johnson & Johnson’s Janssen COVID-19 Vaccine: What Clinicians Need to Know

In the past few weeks more than 7 million doses of Johnson & Johnson’s Janssen COVID-19 vaccine have been administered to people in the United States. In clinical trials of approximately 40,000 people, the J&J vaccine given as a single shot was 66% effective at preventing the illness due to the SARS-CoV-2 virus known as COVID-19. Because the J&J vaccine is a single shot, it has been preferred in some circumstances.


CDC Resources: Administration

SCCM’s COVID-19 Rapid Resource Center now links to pertinent content from the Centers for Disease Control and Prevention (CDC). These resources are categorized as Administration


CDC Resources: Hematology

SCCM’s COVID-19 Rapid Resource Center now links to pertinent content from the Centers for Disease Control and Prevention (CDC). These resources are categorized as Hematology


CDC Resources: Immunology

SCCM’s COVID-19 Rapid Resource Center now links to pertinent content from the Centers for Disease Control and Prevention (CDC). These resources are categorized as Immunology


CDC Resources: Pharmacology

SCCM’s COVID-19 Rapid Resource Center now links to pertinent content from the Centers for Disease Control and Prevention (CDC). These resources are categorized as Pharmacology


COVID-19 Vaccination in Pregnant Individuals​

This resource details vaccinating pregnant patients for COVID-19.

This is SCCM curated COVID-19 microlearning content.


COVID-19 Vaccination: Logistics, Logistics, Logistics

The original webcast served as a COVID-19 vaccination primer that can be used by all types of healthcare workers (HCWs) to help them prepare for Operation Warp Speed and the mass vaccination efforts in the United States. This section of the webcast focused on an COVID-19 vaccination logistics. Webcast Recorded on Friday, January 8, 2021


COVID-19 Vaccine Implementation

The original webcast served as a COVID-19 vaccination primer that can be used by all types of healthcare workers (HCWs) to help them prepare for Operation Warp Speed and the mass vaccination efforts in the United States. This section of the webcast focused on vaccine implementation. Webcast Recorded on Friday, January 8, 2021


COVID-19 Vaccine Storage Considerations

The original webcast served as a COVID-19 vaccination primer that can be used by all types of healthcare workers (HCWs) to help them prepare for Operation Warp Speed and the mass vaccination efforts in the United States. This section of the webcast focused on an vaccine storage considerations. Webcast Recorded on Friday, January 8, 2021


Emerging Vaccines Overview

The original webcast served as a COVID-19 vaccination primer that can be used by all types of healthcare workers (HCWs) to help them prepare for Operation Warp Speed and the mass vaccination efforts in the United States. This section of the webcast focused on an emerging vaccines overview. Webcast Recorded on Friday, January 8, 2021


How will the new COVID-19 variants affect the vaccination strategy?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on February 24, 2021


IDSA Resources: Infection

SCCM’s COVID-19 Rapid Resource Center now links to pertinent content from the Infectious Diseases Society of America (IDSA) COVID-19 Real-Time Learning Network. These resources are categorized as Infection


IDSA Resources: Pharmacology

SCCM’s COVID-19 Rapid Resource Center now links to pertinent content from the Infectious Diseases Society of America (IDSA) COVID-19 Real-Time Learning Network. These resources are categorized as Pharmacology


Prolonged Anaphylaxis to Pfizer Coronavirus Disease 2019 Vaccine: A Case Report and Mechanism of Action

From Critical Care Explorations. In this case report, the authors describe a case of protracted anaphylaxis in a recipient of the BNT162b2


Update on COVID Vaccinations for Pediatric Patients

This resource details vaccinations for pediatric patients during the COVID-19 pandemic. This is SCCM curated COVID-19 microlearning content.


Using Nonheparin Anticoagulant to Treat a Near-Fatal Case With Multiple Venous Thrombotic Lesions During ChAdOx1 nCoV-19 Vaccination-Related Vaccine-Induced Immune Thrombotic Thrombocytopenia

From Critical Care Medicine. The authors describe the successful recovery from multiple and life-threatening venous thrombosis after ChAdOx1 nCoV-19 vaccination.


What outcomes are expected with the new COVID-19 vaccines?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on February 24, 2021